Study . | Design; country; setting . | Patients (M/F) . | Age* . | Matching . | Malocclusion characteristics . | Breathing/airways characteristics . | Extraction . | Appliance; anchorage . | CBCT voxel size . |
---|---|---|---|---|---|---|---|---|---|
Chen 2018 [49] | rNRS; Uni; CHN | EX: 25 (10/15) NEX: 25 (10/15) | EX: 12.2 (NR) NEX: 12.4 (NR) | - | Dental Cl. I; no-mild crowding; ANB 0-4°; average angle/growth type; 1s-SN > 110°; 1i-ML > 99° | No snoring/obstructive sleep apnea/adenoid-/tonsillectomy; normal BMI | 4 × 1st PMs | FA; headgear | NR |
Feizi 2021 [51] | rNRS; Pract; USA | EX: 9 (4/5) NEX: 18 (8/10) | EX: 19.2 (11.0–46.0) NEX: 13.1 (11.0–17.0) | - | Dental Class II (≥ 1/2 cusp); no agenesis (excluding M2/M3); no craniofacial anomaly | - | 4x PMs | FA | 0.3 mm |
Guo 2022 [53] | rNRS; Uni; CHN | EX: 120 (0/120) NEX: 40 (0/40) | EX: 25.1 (20.0–25.0) NEX: 26.4 (20.0–25.0) | Age; skeletal type | Skeletal Class I-II/1 (ANB > 0°, SN-ML > 28°); no Cl. II/2; mild-moderate crowding | BMI < 27 kg/m2; no breathing disorder | 4 × 1st PMs | FA; MX anterior retraction ≥3 mm | 0.3 mm |
Joy 2020 [50] | rNRS; Uni; USA | EX: 41 (20/21) NEX: 42 (22/20) | EX: 26.1 (18.0-NR) NEX: 26.0 (18.0-NR) | Age; sex | Cl. I-III; any crowding | - | 2x MX or 4x PMs | FA/AL; | 0.3 mm |
Leslie 2014 [47] | rNRS; Uni; USA | EX: 64 (23/41) NEX: 90 (42/48) | EX/NEX: NR (NR-18.0) | - | - | - | 4x PMs | FA | 0.4 mm |
Mladenovic 2024coll [54, 55] | rNRS; Pract; AUS | EX: 54 (18/36) NEX: 59 (24/35) | EX/NEX: 15.0 (NR) | Crowding | Skeletal Cl. I-II; any crowding; no craniofacial deformities | - | 2x MX or 4 × 2nd PMs | FA | 0.3 mm |
Mostanghi 2021 [52] | rNRS; Pract; USA | EX: 20 (7/13) NEX: 20 (5/15) | EX: 24.9 (18.5–38.3) NEX: 26.2 (16.0–42.6) | Age; sex; treatment duration | Crowding or bimaxillary dentoalveolar protrusion; no impactions | No reported obstructive sleep apnea | 2x MX or 4x PMs | FA | 0.3 mm |
Pliska 2016 [48] | rNRS; Uni; USA | EX: 26 (8/18) NEX: 48 (17/31) | EX: 27.4 (18.0-NR) NEX: 31.9 (18.0-NR) | - | Cl. I-II (ANB ≥ 0°); no agenesis | - | ≥2x PMs | FA | NR |
Shannon 2012 [45] | rNRS; Pract; USA | EX: 27 (11/16) NEX: 61 (30/31) | EX: 13.5 (9.0–22.0) NEX: 13.2 (10.0–22.0) | - | No agenesis; no craniofacial anomaly | - | 4x PMs | FA | NR |
Stefanovic 2023 [46] | rNRS; Uni; USA | EX: 31 (15/16) NEX: 31 (15/16) | EX: 13.0 (NR) NEX: 12.9 (NR) | Age; sex | Cl. I-III | No breathing disorder | 4 × 1st PMs | FA | 0.38 mm |
Valiathan 2010 [44] | rNRS; Uni; USA | EX: 20 (10/10) NEX: 20 (10/10) | EX: 13.6 (11.3–15.6) NEX: 13.7 (11.3–15.6) | Age, gender, height, ethnicity, weight, BMI, and skeletal features, and oropharynx volume | Cl. I; no craniofacial deformities | No pharyngeal pathology and/or nasal obstruction, snoring, obstructive sleep apnea, adenoid- or tonsillectomy. | 4x PMs | FA | 0.38 mm |
Study . | Design; country; setting . | Patients (M/F) . | Age* . | Matching . | Malocclusion characteristics . | Breathing/airways characteristics . | Extraction . | Appliance; anchorage . | CBCT voxel size . |
---|---|---|---|---|---|---|---|---|---|
Chen 2018 [49] | rNRS; Uni; CHN | EX: 25 (10/15) NEX: 25 (10/15) | EX: 12.2 (NR) NEX: 12.4 (NR) | - | Dental Cl. I; no-mild crowding; ANB 0-4°; average angle/growth type; 1s-SN > 110°; 1i-ML > 99° | No snoring/obstructive sleep apnea/adenoid-/tonsillectomy; normal BMI | 4 × 1st PMs | FA; headgear | NR |
Feizi 2021 [51] | rNRS; Pract; USA | EX: 9 (4/5) NEX: 18 (8/10) | EX: 19.2 (11.0–46.0) NEX: 13.1 (11.0–17.0) | - | Dental Class II (≥ 1/2 cusp); no agenesis (excluding M2/M3); no craniofacial anomaly | - | 4x PMs | FA | 0.3 mm |
Guo 2022 [53] | rNRS; Uni; CHN | EX: 120 (0/120) NEX: 40 (0/40) | EX: 25.1 (20.0–25.0) NEX: 26.4 (20.0–25.0) | Age; skeletal type | Skeletal Class I-II/1 (ANB > 0°, SN-ML > 28°); no Cl. II/2; mild-moderate crowding | BMI < 27 kg/m2; no breathing disorder | 4 × 1st PMs | FA; MX anterior retraction ≥3 mm | 0.3 mm |
Joy 2020 [50] | rNRS; Uni; USA | EX: 41 (20/21) NEX: 42 (22/20) | EX: 26.1 (18.0-NR) NEX: 26.0 (18.0-NR) | Age; sex | Cl. I-III; any crowding | - | 2x MX or 4x PMs | FA/AL; | 0.3 mm |
Leslie 2014 [47] | rNRS; Uni; USA | EX: 64 (23/41) NEX: 90 (42/48) | EX/NEX: NR (NR-18.0) | - | - | - | 4x PMs | FA | 0.4 mm |
Mladenovic 2024coll [54, 55] | rNRS; Pract; AUS | EX: 54 (18/36) NEX: 59 (24/35) | EX/NEX: 15.0 (NR) | Crowding | Skeletal Cl. I-II; any crowding; no craniofacial deformities | - | 2x MX or 4 × 2nd PMs | FA | 0.3 mm |
Mostanghi 2021 [52] | rNRS; Pract; USA | EX: 20 (7/13) NEX: 20 (5/15) | EX: 24.9 (18.5–38.3) NEX: 26.2 (16.0–42.6) | Age; sex; treatment duration | Crowding or bimaxillary dentoalveolar protrusion; no impactions | No reported obstructive sleep apnea | 2x MX or 4x PMs | FA | 0.3 mm |
Pliska 2016 [48] | rNRS; Uni; USA | EX: 26 (8/18) NEX: 48 (17/31) | EX: 27.4 (18.0-NR) NEX: 31.9 (18.0-NR) | - | Cl. I-II (ANB ≥ 0°); no agenesis | - | ≥2x PMs | FA | NR |
Shannon 2012 [45] | rNRS; Pract; USA | EX: 27 (11/16) NEX: 61 (30/31) | EX: 13.5 (9.0–22.0) NEX: 13.2 (10.0–22.0) | - | No agenesis; no craniofacial anomaly | - | 4x PMs | FA | NR |
Stefanovic 2023 [46] | rNRS; Uni; USA | EX: 31 (15/16) NEX: 31 (15/16) | EX: 13.0 (NR) NEX: 12.9 (NR) | Age; sex | Cl. I-III | No breathing disorder | 4 × 1st PMs | FA | 0.38 mm |
Valiathan 2010 [44] | rNRS; Uni; USA | EX: 20 (10/10) NEX: 20 (10/10) | EX: 13.6 (11.3–15.6) NEX: 13.7 (11.3–15.6) | Age, gender, height, ethnicity, weight, BMI, and skeletal features, and oropharynx volume | Cl. I; no craniofacial deformities | No pharyngeal pathology and/or nasal obstruction, snoring, obstructive sleep apnea, adenoid- or tonsillectomy. | 4x PMs | FA | 0.38 mm |
AL, aligner; BMI, body mass index; CBCT, cone-bean computerized tomography; Cl., Angle’s Class; coll, collated multiple reports; CVM, cervical vertebrae maturation; EX, extraction group; FA, fixed appliance; M2/M3, 2nd/3rd molar; MX, maxillary; NEX, non-extraction group; NR, not reported; PM, premolar; Pract, private practice; rNRS, retrospective non-randomized study.
Study . | Design; country; setting . | Patients (M/F) . | Age* . | Matching . | Malocclusion characteristics . | Breathing/airways characteristics . | Extraction . | Appliance; anchorage . | CBCT voxel size . |
---|---|---|---|---|---|---|---|---|---|
Chen 2018 [49] | rNRS; Uni; CHN | EX: 25 (10/15) NEX: 25 (10/15) | EX: 12.2 (NR) NEX: 12.4 (NR) | - | Dental Cl. I; no-mild crowding; ANB 0-4°; average angle/growth type; 1s-SN > 110°; 1i-ML > 99° | No snoring/obstructive sleep apnea/adenoid-/tonsillectomy; normal BMI | 4 × 1st PMs | FA; headgear | NR |
Feizi 2021 [51] | rNRS; Pract; USA | EX: 9 (4/5) NEX: 18 (8/10) | EX: 19.2 (11.0–46.0) NEX: 13.1 (11.0–17.0) | - | Dental Class II (≥ 1/2 cusp); no agenesis (excluding M2/M3); no craniofacial anomaly | - | 4x PMs | FA | 0.3 mm |
Guo 2022 [53] | rNRS; Uni; CHN | EX: 120 (0/120) NEX: 40 (0/40) | EX: 25.1 (20.0–25.0) NEX: 26.4 (20.0–25.0) | Age; skeletal type | Skeletal Class I-II/1 (ANB > 0°, SN-ML > 28°); no Cl. II/2; mild-moderate crowding | BMI < 27 kg/m2; no breathing disorder | 4 × 1st PMs | FA; MX anterior retraction ≥3 mm | 0.3 mm |
Joy 2020 [50] | rNRS; Uni; USA | EX: 41 (20/21) NEX: 42 (22/20) | EX: 26.1 (18.0-NR) NEX: 26.0 (18.0-NR) | Age; sex | Cl. I-III; any crowding | - | 2x MX or 4x PMs | FA/AL; | 0.3 mm |
Leslie 2014 [47] | rNRS; Uni; USA | EX: 64 (23/41) NEX: 90 (42/48) | EX/NEX: NR (NR-18.0) | - | - | - | 4x PMs | FA | 0.4 mm |
Mladenovic 2024coll [54, 55] | rNRS; Pract; AUS | EX: 54 (18/36) NEX: 59 (24/35) | EX/NEX: 15.0 (NR) | Crowding | Skeletal Cl. I-II; any crowding; no craniofacial deformities | - | 2x MX or 4 × 2nd PMs | FA | 0.3 mm |
Mostanghi 2021 [52] | rNRS; Pract; USA | EX: 20 (7/13) NEX: 20 (5/15) | EX: 24.9 (18.5–38.3) NEX: 26.2 (16.0–42.6) | Age; sex; treatment duration | Crowding or bimaxillary dentoalveolar protrusion; no impactions | No reported obstructive sleep apnea | 2x MX or 4x PMs | FA | 0.3 mm |
Pliska 2016 [48] | rNRS; Uni; USA | EX: 26 (8/18) NEX: 48 (17/31) | EX: 27.4 (18.0-NR) NEX: 31.9 (18.0-NR) | - | Cl. I-II (ANB ≥ 0°); no agenesis | - | ≥2x PMs | FA | NR |
Shannon 2012 [45] | rNRS; Pract; USA | EX: 27 (11/16) NEX: 61 (30/31) | EX: 13.5 (9.0–22.0) NEX: 13.2 (10.0–22.0) | - | No agenesis; no craniofacial anomaly | - | 4x PMs | FA | NR |
Stefanovic 2023 [46] | rNRS; Uni; USA | EX: 31 (15/16) NEX: 31 (15/16) | EX: 13.0 (NR) NEX: 12.9 (NR) | Age; sex | Cl. I-III | No breathing disorder | 4 × 1st PMs | FA | 0.38 mm |
Valiathan 2010 [44] | rNRS; Uni; USA | EX: 20 (10/10) NEX: 20 (10/10) | EX: 13.6 (11.3–15.6) NEX: 13.7 (11.3–15.6) | Age, gender, height, ethnicity, weight, BMI, and skeletal features, and oropharynx volume | Cl. I; no craniofacial deformities | No pharyngeal pathology and/or nasal obstruction, snoring, obstructive sleep apnea, adenoid- or tonsillectomy. | 4x PMs | FA | 0.38 mm |
Study . | Design; country; setting . | Patients (M/F) . | Age* . | Matching . | Malocclusion characteristics . | Breathing/airways characteristics . | Extraction . | Appliance; anchorage . | CBCT voxel size . |
---|---|---|---|---|---|---|---|---|---|
Chen 2018 [49] | rNRS; Uni; CHN | EX: 25 (10/15) NEX: 25 (10/15) | EX: 12.2 (NR) NEX: 12.4 (NR) | - | Dental Cl. I; no-mild crowding; ANB 0-4°; average angle/growth type; 1s-SN > 110°; 1i-ML > 99° | No snoring/obstructive sleep apnea/adenoid-/tonsillectomy; normal BMI | 4 × 1st PMs | FA; headgear | NR |
Feizi 2021 [51] | rNRS; Pract; USA | EX: 9 (4/5) NEX: 18 (8/10) | EX: 19.2 (11.0–46.0) NEX: 13.1 (11.0–17.0) | - | Dental Class II (≥ 1/2 cusp); no agenesis (excluding M2/M3); no craniofacial anomaly | - | 4x PMs | FA | 0.3 mm |
Guo 2022 [53] | rNRS; Uni; CHN | EX: 120 (0/120) NEX: 40 (0/40) | EX: 25.1 (20.0–25.0) NEX: 26.4 (20.0–25.0) | Age; skeletal type | Skeletal Class I-II/1 (ANB > 0°, SN-ML > 28°); no Cl. II/2; mild-moderate crowding | BMI < 27 kg/m2; no breathing disorder | 4 × 1st PMs | FA; MX anterior retraction ≥3 mm | 0.3 mm |
Joy 2020 [50] | rNRS; Uni; USA | EX: 41 (20/21) NEX: 42 (22/20) | EX: 26.1 (18.0-NR) NEX: 26.0 (18.0-NR) | Age; sex | Cl. I-III; any crowding | - | 2x MX or 4x PMs | FA/AL; | 0.3 mm |
Leslie 2014 [47] | rNRS; Uni; USA | EX: 64 (23/41) NEX: 90 (42/48) | EX/NEX: NR (NR-18.0) | - | - | - | 4x PMs | FA | 0.4 mm |
Mladenovic 2024coll [54, 55] | rNRS; Pract; AUS | EX: 54 (18/36) NEX: 59 (24/35) | EX/NEX: 15.0 (NR) | Crowding | Skeletal Cl. I-II; any crowding; no craniofacial deformities | - | 2x MX or 4 × 2nd PMs | FA | 0.3 mm |
Mostanghi 2021 [52] | rNRS; Pract; USA | EX: 20 (7/13) NEX: 20 (5/15) | EX: 24.9 (18.5–38.3) NEX: 26.2 (16.0–42.6) | Age; sex; treatment duration | Crowding or bimaxillary dentoalveolar protrusion; no impactions | No reported obstructive sleep apnea | 2x MX or 4x PMs | FA | 0.3 mm |
Pliska 2016 [48] | rNRS; Uni; USA | EX: 26 (8/18) NEX: 48 (17/31) | EX: 27.4 (18.0-NR) NEX: 31.9 (18.0-NR) | - | Cl. I-II (ANB ≥ 0°); no agenesis | - | ≥2x PMs | FA | NR |
Shannon 2012 [45] | rNRS; Pract; USA | EX: 27 (11/16) NEX: 61 (30/31) | EX: 13.5 (9.0–22.0) NEX: 13.2 (10.0–22.0) | - | No agenesis; no craniofacial anomaly | - | 4x PMs | FA | NR |
Stefanovic 2023 [46] | rNRS; Uni; USA | EX: 31 (15/16) NEX: 31 (15/16) | EX: 13.0 (NR) NEX: 12.9 (NR) | Age; sex | Cl. I-III | No breathing disorder | 4 × 1st PMs | FA | 0.38 mm |
Valiathan 2010 [44] | rNRS; Uni; USA | EX: 20 (10/10) NEX: 20 (10/10) | EX: 13.6 (11.3–15.6) NEX: 13.7 (11.3–15.6) | Age, gender, height, ethnicity, weight, BMI, and skeletal features, and oropharynx volume | Cl. I; no craniofacial deformities | No pharyngeal pathology and/or nasal obstruction, snoring, obstructive sleep apnea, adenoid- or tonsillectomy. | 4x PMs | FA | 0.38 mm |
AL, aligner; BMI, body mass index; CBCT, cone-bean computerized tomography; Cl., Angle’s Class; coll, collated multiple reports; CVM, cervical vertebrae maturation; EX, extraction group; FA, fixed appliance; M2/M3, 2nd/3rd molar; MX, maxillary; NEX, non-extraction group; NR, not reported; PM, premolar; Pract, private practice; rNRS, retrospective non-randomized study.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.